Skip to content
10-Q

Quarterly Report

Checkmate Pharmaceuticals, Inc.

0001193125-21-244686

← back to feed
Filed
Aug 12, 2021 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2021 · Aug 11, 2021 21.63M sh
Operating Cash Flow Q2 2021 · Jun 30, 2021 −$29.7M
Operating Cash Flow Q2 2021 · Jun 30, 2020 −$16.04M
Cash And Equivalents Q2 2021 · Jun 30, 2021 $63.11M
Cash And Equivalents Q2 2021 · Dec 31, 2020 $43.06M
Stockholders Equity Q2 2021 · Jun 30, 2021 $94.98M
Stockholders Equity Q2 2021 · Mar 31, 2021 $112.4M
Stockholders Equity Q2 2021 · Dec 31, 2020 $125.2M
Stockholders Equity Q2 2021 · Jun 30, 2020 −$117.8M
Stockholders Equity Q2 2021 · Mar 31, 2020 −$106.93M
Stockholders Equity Q2 2021 · Dec 31, 2019 −$97.44M
Current Liabilities Q2 2021 · Jun 30, 2021 $6.7M
Current Liabilities Q2 2021 · Dec 31, 2020 $7.88M
Total Liabilities Q2 2021 · Jun 30, 2021 $6.7M
Total Liabilities Q2 2021 · Dec 31, 2020 $7.88M
Current Assets Q2 2021 · Jun 30, 2021 $91.07M
Current Assets Q2 2021 · Dec 31, 2020 $102.1M
Total Assets Q2 2021 · Jun 30, 2021 $101.68M
Total Assets Q2 2021 · Dec 31, 2020 $133.07M
Sga Expense Q2 2021 · Jun 30, 2021 $4.09M
Sga Expense Q2 2021 · Jun 30, 2021 $7.89M
Sga Expense Q2 2021 · Jun 30, 2020 $1.8M
Sga Expense Q2 2021 · Jun 30, 2020 $3.31M
Rd Expense Q2 2021 · Jun 30, 2021 $14.87M
Rd Expense Q2 2021 · Jun 30, 2021 $25.24M
Rd Expense Q2 2021 · Jun 30, 2020 $6.48M
Rd Expense Q2 2021 · Jun 30, 2020 $12.79M
Net Income Q2 2021 · Jun 30, 2021 −$18.97M
Net Income Q2 2021 · Jun 30, 2021 −$33.1M
Net Income Q2 2021 · Mar 31, 2021 −$14.13M
Net Income Q2 2021 · Jun 30, 2020 −$8.35M
Net Income Q2 2021 · Jun 30, 2020 −$16.15M
Net Income Q2 2021 · Mar 31, 2020 −$7.8M
Operating Income Q2 2021 · Jun 30, 2021 −$18.96M
Operating Income Q2 2021 · Jun 30, 2021 −$33.14M
Operating Income Q2 2021 · Jun 30, 2020 −$8.27M
Operating Income Q2 2021 · Jun 30, 2020 −$16.09M